» Articles » PMID: 38235136

Novel Antioxidant Protein Target Therapy to Counter the Prevalence and Severity of SARS-CoV-2

Overview
Journal Front Immunol
Date 2024 Jan 18
PMID 38235136
Authors
Affiliations
Soon will be listed here.
Abstract

Background: This review analyzed the magnitude of the COVID-19 pandemic globally and in India and the measures to counter its effect using natural and innate immune booster molecules. The study focuses on two phases: the first focuses on the magnitude, and the second on the effect of antioxidants (natural compounds) on SARS-CoV-2.

Methods: The magnitude of the prevalence, mortality, and comorbidities was acquired from the World Health Organization (WHO) report, media, a report from the Ministry of Health and Family Welfare (MoHFW), newspapers, and the National Centre of Disease Control (NCDC). Research articles from PubMed as well as other sites/journals and databases were accessed to gather literature on the effect of antioxidants.

Results: In the elderly and any chronic diseases, the declined level of antioxidant molecules enhanced the reactive oxygen species, which in turn deprived the immune system.

Conclusion: Innate antioxidant proteins like sirtuin and sestrin play a vital role in enhancing immunity. Herbal products and holistic approaches can also be alternative solutions for everyday life to boost the immune system by improving the redox balance in COVID-19 attack. This review analyzed the counteractive effect of alternative therapy to boost the immune system against the magnitude of the COVID-19 pandemic.

Citing Articles

Distinct profiles of osteoclast and dendritic cell-mediated expansion and functional activation of NK and T cells.

Kaur K, Jewett A Cancer Immunol Immunother. 2025; 74(4):127.

PMID: 40024920 PMC: 11872835. DOI: 10.1007/s00262-025-03956-x.

References
1.
Shekhar S, Yadav Y, Singh A, Pradhan R, Desai G, Dey A . Neuroprotection by ethanolic extract of Syzygium aromaticum in Alzheimer's disease like pathology via maintaining oxidative balance through SIRT1 pathway. Exp Gerontol. 2018; 110:277-283. DOI: 10.1016/j.exger.2018.06.026. View

2.
Krueger J, Suarez-Farinas M, Cueto I, Khacherian A, Matheson R, Parish L . A Randomized, Placebo-Controlled Study of SRT2104, a SIRT1 Activator, in Patients with Moderate to Severe Psoriasis. PLoS One. 2015; 10(11):e0142081. PMC: 4640558. DOI: 10.1371/journal.pone.0142081. View

3.
Colpitts C, Schang L . A small molecule inhibits virion attachment to heparan sulfate- or sialic acid-containing glycans. J Virol. 2014; 88(14):7806-17. PMC: 4097786. DOI: 10.1128/JVI.00896-14. View

4.
Vilhelmova-Ilieva N, Petrova Z, Georgieva A, Tzvetanova E, Trepechova M, Mileva M . Anti-Coronavirus Efficiency and Redox-Modulating Capacity of Polyphenol-Rich Extracts from Traditional Bulgarian Medicinal Plants. Life (Basel). 2022; 12(7). PMC: 9319587. DOI: 10.3390/life12071088. View

5.
Altay O, Arif M, Li X, Yang H, Aydin M, Alkurt G . Combined Metabolic Activators Accelerates Recovery in Mild-to-Moderate COVID-19. Adv Sci (Weinh). 2021; 8(17):e2101222. PMC: 8420376. DOI: 10.1002/advs.202101222. View